During the past decade, Sands Cancer Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 12 clinical trials were completed, i.e. on average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sands Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 10 trials, followed by "National Cancer Institute (NCI)" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "NRG Oncology" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sands Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Sands Cancer Center" are "Prostate Cancer" (5 trials), "Breast Cancer" (4 trials), "Lung Cancer" (3 trials), "Endometrial Clear Cell Adenocarcinoma" (2 trials) and "Endometrial Serous Adenocarcinoma" (2 trials). Many other conditions were trialed in "Sands Cancer Center" in a lesser frequency.

Most popular intervention types in "Sands Cancer Center" are "Radiation" (27 trials), "Drug" (21 trials), "Other" (14 trials), "Biological" (8 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (9 trials), "Laboratory Biomarker Analysis" (8 trials), "Carboplatin" (7 trials), "Paclitaxel" (7 trials) and "Radiation Therapy" (6 trials). Other intervention names were less common.

The vast majority of trials in "Sands Cancer Center" are 19 trials for "All" genders, 7 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Sands Cancer Center". undefined are not yet recruiting, 8 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sands Cancer Center, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sands Cancer Center, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".